VETIVA RESEARCH

Similar documents
VETIVA RESEARCH BUY. SEPLAT PETROLEUM DEVELOPMENT COMPANY Outlook remains positive despite earnings miss. Equity Research 9 May 2018

VETIVA RESEARCH SELL. GUINNESS NIGERIA PLC Q3 sales hit 6 year low. Equity Research 25 April 2016

VETIVA RESEARCH BUY. SEPLAT PETROLEUM DEVELOPMENT COMPANY Solid FY 18 operations in view. Equity Research 1 March 2018

ASHAKACEM. Vetiva Research. Q3 10 Earnings Release. Margins under pressure? 4 November Fair Value Range N21.76 N24.05

NESTLE NIGERIA PLC. Vetiva Research 26 October Q3 10 Earnings Release. Organic Growth on Track. Fair Value Range N N426.

LAFARGE WAPCO CEMENT PLC

Latest FY 16 result shows a percent YoY growth in Gross

ACCESS BANK RIGHTS ISSUE

Okomu Oil Palm Plc. Lower revenues, higher costs weaker profits. Equity Research PZ Cussons Nigeria. Nigeria Equities Consumer Goods December

BERGER PAINTS NIGERIA PLC

MONTHLY ECONOMIC NOTE APRIL 2011

SEVEN-UP BOTTLING COMPANY PLC

Earnings Update Guaranty Trust Bank PLC: Q Results

Nigeria Equities Financial Services August 23,

LAFARGE CEMENT WAPCO NIGERIA PLC

FLOUR MILLS OF NIGERIA PLC

FIRST BANK OF NIGERIA HOLDCO. (FBNH)

Dangote Cement Plc. Higher Volume, Improved Pricing and Exchange Rate Benefit Impact Earnings. Nigeria Equities Industrial Goods May 18, 2018

Dangote Cement Plc. Improved Product Pricing Boosts Earnings. Nigeria Equities Industrial Goods April 3, 2018

SEVEN-UP BOTTLING COMPANY PLC

GUARANTY TRUST BANK PLC

Is this Rally a Re-birth?

Zenith Bank Plc. Earnings Below Expectation: Lower Provision for Loan Loss Saves the Day. Nigeria Equities Financial Services August 15, 2018

BERGER PAINTS NIGERIA PLC

Company Update: Fidson Healthcare Plc

CADBURY NIGERIA PLC. Tough Operating Environment Remain Achilles heel of Nigeria s Top Chocolate & Confectionary Maker 21 OCTOBER, 2015

Guaranty Trust Bank Plc

Industrial Goods I Cement

PBT growth slightly ahead of FY guidance. 9th November 2015 EQUITY RESEARCH THE COOPERATIVE BANK 3Q15 RESULTS REVIEW

Unilever Nigeria Plc. Cost control remains a challenge. Nigeria Equities Consumer Goods July 24, 2015

Presentation to Investors

UNILEVER NIGERIA PLC. Vetiva Research 08 September Q2 10 Earnings Release. Closing up unimpressively. Fair Value Range N17.50 N21.

FIDSON PLC. Investment Summary & Highlight. Fidson PLC: a see-saw to the top? MorganCapital Research. July 10, 2013

UAC Nigeria Plc. New acquisitions bolster revenue growth. Nigeria Equities Conglomerate November 08, 2013

The Concord Team Adedamola Onakade Kolawole Ogunbowale

Guinness Nigeria Plc. Revenue growth remains a challenge. Nigeria Equities Breweries November 22, 2013

WEEKLY STOCK MARKET REVIEW

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Coal India. Source: Company Data; PL Research

Change EPS. (Rs) FY

Quarterly results (YE Mar) 4QFY13 4QFY14 YoY(%) FY13 FY14 YoY(%)

Q1 Q2 Q3 (QtD) YtD. Projected PAT (N' Billion) Projected EPS (N) ACCESS

Flour Mills of Nigeria Plc

FIRST ONLINE REAL TIME

WEEKLY STOCK MARKET REVIEW

Visaka Industries Ltd

Hindustan Unilever (RHS)

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Coal India. Source: Company Data; PL Research

DX (Group) plc* Industrial Transportation. Successful HMPO tender improves forecast certainty. Price 17.75p. Price Performance. Financial Forecasts

Ahluwalia Contracts (India)

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Monthly Market Wrap. Nigerian All Share Index declines by 6.17% in January 2017 Nigerian Equity Market

ITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only

Equity Research

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Mahindra & Mahindra Ltd.

Coal India. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Fineotex Chemical Ltd

WILMAR INTERNATIONAL LIMITED 1Q2016 Results Highlights. May 10, 2016

TVS Motors. Source: Company Data; PL Research

Nestle India Ltd. RESULT UPDATE

Simplex Infrastructures

Earnings get stamina from pension stake disposal

TCL Communication (2618 HK) Painful transition period. Buy (Maintain) Target Price HK$2.33 Up/downside +28.5% Current price HK$1.

Honeywell Flour Mills Plc

Cummins India Ltd Bloomberg Code: KKC IN

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

WILMAR INTERNATIONAL LIMITED 1Q2017 Results Highlights. May 11, 2017

Result Update. Sterling Tools. Buy

Bajaj Auto Ltd. CMP: Rs.1426 Recommendation: Buy Target Price: Rs March. 1 P age. 21 st July Key Data Financial Year End

Flour Mills of Nigeria Plc

Larsen & Toubro Ltd.

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

Partnership Investment Company Limited: Offer by Private Placement

Sime Darby SIME MK Sector: Plantation

Economic Update. Non-oil sector resilience: How sustainable is the recovery? Nigeria Economy 4Q 17 & FY 17 GDP Report March 22, 2018

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

OMAX.BO 1QFY13 Result Impressive uptick in margins. Promoters 89 grow. Continued focus on plotted development and low rise (with less construction

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Norges Bank Review 24 September 2015

Market Access. M&A Securities. Results Review (1Q15) TSH Resources Berhad HOLD (TP: RM2.38) A Tough Quarter - More Room to Grow.

Equity Research

BUY STEEL STRIPS WHEELS LTD. Target Price: Rs Q4FY17: Heavier wheels outperform, strong growth triggers ahead FINANCIAL SUMMARY

One Year Price Performance

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

Market Access. Results Review (4Q14) M&A Securities. Genting Plantations Berhad. Hit by Plantation-Malaysia Segment. Thursday, May 28, 2015

WILMAR INTERNATIONAL LIMITED 4Q2016 Results Briefing. Feb 20, 2017

Saudi Arabia BUY. Result Update. Saudi International Petrochemical Company (SIPCHEM) CMP: SR18.2 (as on May 03, 2009) Highlights

Luk Fook (590 HK) Hold Target price: HK$ Downgrade to Hold on more challenging HK & Macau market outlook. Equity Research Consumer Discretionary

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Punjab National Bank

Lafarge Africa Plc. (WAPCO.NL)

Closed-End Equity Funds

LARGE CAP & 1,970 BSE

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

East African Breweries Limited

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Transcription:

NIGERIA EQUITY AGRICULTURE CROP PRODUCTION OKOMUOIL Earnings Release VETIVA RESEARCH www.vetiva.com OKOMU OIL PALM COMPANY PLC Earnings remain strong despite seasonal slowdown 9M 16 PBT doubles, 24% ahead of estimate Earnings growth outlook remains strong Cautious stance maintained on Q4 earnings Valuation revised higher despite cautious stance on Q4 earnings Similar to recent earnings from listed peer, OKOMUOIL s 9M 16 results came in strong with PBT up 100% y/y to N5.1 billion, 6% ahead of our estimate. As expected, Q3 revenue from the Oil Palm segment came off the Q2 record numbers (down 29% q/q to N2.7 billion) as seasonal effect weighed on volume; H2 is traditionally an off-peak period for Crude Palm Oil (CPO) production. When compared to the corresponding period of 2015 however (for better comparison), the 3-month Oil Palm revenue was up 27% y/y on the back of strong local CPO prices. Q3 revenue from the Rubber segment (export) also increased 5% y/y to N653 million largely supported by weaker naira which offset the impact of lower rubber prices. OKOMUOIL s overall 9M revenue rose 41% y/y to N10.9 billion, slightly below our N11.4 billion estimate. Earnings growth outlook remains strong Given that palm oil remains on the list of 41-items excluded from accessing official FX market, the outlook for oil palm pricing remains positive and key in driving OKOMUOIL s earnings in coming quarters. Moving away from prices however, we should highlight that we are equally positive on OKOMUOIL s organic growth outlook given management commitment to expansion projects. We understand that 4,000ha of the 10,000ha Extension 2 (latest acquired plantation) have been planted with oil palm seedlings till date. In 3-4 years time when the oil palm trees begin to yield oil palm fruits in commercial quantity, we expect to see growth in CPO production. Also, with the government still quite bullish on agriculture as a viable revenue diversification route, coupled with its increased drive to support local production, we expect OKOMUOIL to continue benefiting from protectionist policies in the near term. With this expected to keep local CPO prices strong, we improve our already positive outlook on earnings from OKOMUOIL s oil palm segment. On the rubber front, we highlight that international natural rubber prices have increased by 27% from August low amidst a couple of factors - strengthening car sales in China (largest consumer of rubber), concern on output from Thailand and an uptrend in price of synthetic rubber (substitute to natural rubber). Coupled with exchange rate impact, we expect further margin improvement from the OKOMUOIL s rubber segment. Valuation revised higher despite cautious stance on Q4 earnings Notwithstanding the more positive outlook on the rubber segment in Q4, we cut our FY 16 revenue forecast to N14.6 billion (Previous: N15.1 billion) as we further factor in the off-peak period effect of the oil palm sector in our model. Also, we take a cautious stance on Q4 earnings as we make provision for higher quarter s cost of sales (as a % of sales) in line with the spike observed in Q4 15 (111% of sales) amidst recognition of development costs in Extension 2. We note that more work has been done on the Extension 2 in 2016, however, 9M 16 cost of sales (as a % of sales) remains modest at 12% (9M 15: 16%). Be that as it may, FY 16 earnings will come in as record high, even as 9M earnings have already surpassed FY 15 level. We maintain our FY 16 PAT at N4.9 billion. Our target price has however been revised slightly higher to N48.81 (Previous: N45.18), supported by our improved post-2016 earnings outlook. Target price Company Statistics Price (N) Market Cap (N Mn) Net Cash (N Mn) Enterprise Value (N Mn) Shares Outstanding (Mn) NSE Bloomberg Reuters Ownership Structure SOCFIN Others Tominiyi Ramon* t.ramon@vetiva.com Equity Research 14 November 2016 HOLD Share Price Performance 30 days YtD 365 days 1.8 1.5 1.3 1.0 N48.81 42.47 40,513 1,200 39,313 954 OKOMUOIL.NL OKOMUOIL.LG OKOMUOIL.LG Price Movement (Rebased) 62.7% 37.3% 5.9% 46.4% 47.0% 0.8 Nov-15 Feb-16 May-16 Aug-16 Nov-16 OKOMU Business Description NSE ASI Source: NSE, Vetiva Research Okomu Oil Palm Company PLC. is an indigenous agro-allied company engaged in the cultivation of oil palm, processing of fresh fruit bunches into crude palm oil for resale, rubber plantation and processing of rubber lumps into rubber cake for export. The company was established in 1976 as a Federal Government pilot project covering an area of 15,580 hectares and was incorporated as a private limited liability company in 1979. Vetiva Capital Management Limited Lagos Office: Plot 266B Kofo Abayomi Street Victoria Island Lagos Nigeria +234-1-4617521-3 Abuja Office: Floor 02 Transcorp Hilton Hotel Abuja +234-9-8700686 Please Read: Important disclosures and analyst s certification appear in Appendix 1

N'million 9M'16 9M'15 Y/Y Chg Vetiva Estimates Variance Revenue 10,912 7,750 41% 11,415-4% Gross Profit 9,655 6,525 48% 9,103 6% OPEX -4,318-3,657 18% -4,334 0% EBIT 5,337 2,868 86% 5,075 5% Net interest expenses -422-349 21% -234 80% PBT 5,109 2,556 100% 4,841 6% PAT 4,176 2,205 89% 4,248-2% Gross Margin 88.5% 84.2% 79.7% EBIT Margin 48.9% 37.0% 44.5% PAT Margin 38.3% 28.5% 37.2% Income Statement FY14A FY15A FY16E FY17F FY18F FY14A FY15A FY16E FY17F FY18F N'mil N'mil N'mil N'mil N'mil $'mil $'mil $'mil $'mil $'mil Revenues 8,656 9,738 14,651 16,077 17,551 47 49 45 49 54 Cost of Sales -3,891-3,425-3,077-3,537-4,037-21 -17-9 -11-12 Gross Profit 4,765 6,313 11,574 12,540 13,514 26 32 36 39 42 OPEX -3,005-3,321-5,641-6,109-6,669-16 -17-17 -19-21 Operating income 1,760 2,992 5,934 6,431 6,845 10 15 18 20 21 Other gains/loss 192 286 293 322 351 1 1 1 1 1 EBITDA 2,910 4,423 7,334 7,938 8,464 16 22 23 24 26 Depreciation -958-1,145-1,108-1,186-1,268-5 -6-3 -4-4 EBIT 1,952 3,278 6,227 6,752 7,196 11 16 19 21 22 Interest expense -142-429 -303-230 -173-1 -2-1 -1-1 PBT 1,904 2,899 5,924 6,522 7,023 10 15 18 20 22 Income tax -345-268 -1,066-1,174-1,264-2 -1-3 -4-4 PAT 1,330 2,631 4,857 5,348 5,759 7 13 15 16 18 Balance Sheet FY14A FY15A FY16E FY17F FY18F FY14A FY15A FY16E FY17F FY18F N'mil N'mil N'mil N'mil N'mil $'mil $'mil $'mil $'mil $'mil Trade payables 772 889 923 1,061 1,211 4 4 3 3 4 Current provision and accruals 359 483 483 483 483 2 2 1 1 1 Other current liabilities 2,286 340 0 0 0 12 2 0 0 0 Current tax liabilites 1,003 612 612 612 612 5 3 2 2 2 Deferred tax liabilities 1,705 1,733 1,733 1,733 1,733 9 9 5 5 5 Financial liabilities 1,477 3,386 3,077 2,400 1,723 8 17 9 7 5 Share capital 477 477 477 477 477 3 2 1 1 1 Share premium 1,867 1,867 1,867 1,867 1,867 10 9 6 6 6 Revenue reserves 7,260 9,720 14,482 18,876 23,681 40 49 45 58 73 Total Liabilities & Equity 17,872 20,053 24,200 28,056 32,333 97 101 74 86 99 Inventories 1,416 1,491 1,538 1,768 2,018 8 7 5 5 6 Trade and other receivables 105 63 733 804 878 1 0 2 2 3 Other receivables and short term prepayment 627 297 943 1,035 1,130 3 1 3 3 3 Cash and cash equivalents 358 958 2,747 5,221 8,102 2 5 8 16 25 Property, plant and equipment 10,255 9,849 9,705 9,588 9,496 56 49 30 30 29 Biological assets 5,111 7,396 8,535 9,639 10,710 28 37 26 30 33 Total Assets 17,872 20,053 24,200 28,056 32,333 97 101 74 86 99 2

Cashflow statement FY14A FY15A FY16E FY17F FY18F FY14A FY15A FY16E FY17F FY18F N'mil N'mil N'mil N'mil N'mil $'mil $'mil $'mil $'mil $'mil Operating activities 3,166 3,999 4,938 6,509 6,931 17 20 15 20 21 Investment Activities -5,133-3,124-2,102-2,173-2,247-28 -16-6 -7-7 Financing Activities -743 1,611-1,048-1,861-1,804-4 8-3 -6-6 Net Cashflow -2,710 2,486 1,788 2,474 2,880-15 12 6 8 9 Opening cash balance 1,182-1,528 958 2,747 5,221 6-8 3 8 16 Closing Balance 358 958 2,747 5,221 8,102 2 5 8 16 25 Growth (%) FY13A FY14A FY15A FY16F FY17F FY18F Revenue -13% -2% 13% 50% 10% 9% EBITDA -32% -12% 52% 66% 8% 7% EBIT -40% -25% 68% 90% 8% 7% PBT -38% -29% 52% 104% 10% 8% PAT -42% -36% 98% 85% 10% 8% Profitability (%) FY13A FY14A FY15A FY16F FY17F FY18F ROAE 9% 8% 24% 34% 28% 24% ROAA 7% 6% 14% 22% 20% 19% EBITDA Margin 37% 34% 45% 50% 49% 48% EBIT Margin 29% 23% 34% 43% 42% 41% PBT Margin 30% 22% 30% 40% 41% 40% PAT Margin 24% 15% 27% 33% 33% 33% Per share data (N) FY13A FY14A FY15A FY16E FY17F FY18F Earnings/share 2.19 1.39 2.76 5.09 5.61 6.04 Dividend/share 1.00 0.25 0.10 1.00 1.00 1.50 Net Asset/share 23.71 10.07 12.65 17.64 22.25 27.28 3

Disclosures Section The research analyst(s) denoted by an * on the cover of this report certifies (or, where multiple research analysts are primarily responsible for this report, the research analysts denoted by an * on the cover or within the document individually certifies, with respect to each security or issuer that the research analyst(s) cover in this research) that: (1) all of the views expressed in this report accurately articulate the research analyst(s) independent views/opinions, based on public information regarding the companies, securities, industries or markets discussed in this report. (2) The research analyst(s) compensation or remuneration is in no way connected (either directly or indirectly) to the specific recommendations, estimates or opinions expressed in this report. Ratings Definitions Vetiva uses the following rating system: Buy rating refers to stocks that we consider highly undervalued, but with strong fundamentals, and where potential return in excess of or equal to 15.00% is expected to be realized between the current price and analysts target price. Hold rating refers to stocks that we consider correctly valued with little upside or downside, and where potential return between +5.00 and+14.99% is expected to be realized between current price and analysts target price. Sell rating refers to stocks that we consider overvalued, but with good or weakening fundamentals, and where potential return below +5.00% is expected to be realized between current price and analysts target price. Rating Suspended: applies to a stock when investment rating has been suspended because there is no sufficient fundamental basis for determining, or there are legal, regulatory or policy constraints around publishing, an investment rating or target price. Analysts Compensation: The research analyst(s) responsible for the preparation of this report receive compensation based upon various factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues, which include revenues from, among other business units, Investment Banking and Wealth Management. Valuation and Risks: Please see the most recent company-specific research report for an analysis of valuation methodology and risks on any security recommended herein. You can contact the analyst named on the front of this note for further details. Frequency of Next Update: An update of our view on the company would be provided when next there are substantial developments/financial news on the company. Conflict of Interest: It is the policy of Vetiva Capital Management Limited and its subsidiaries and affiliates (individually and collectively referred to as Vetiva ) that research analysts may not be involved in activities that suggest that they are representing the interests of Vetiva in a way likely to appear to be inconsistent with providing independent investment research. In addition, research analysts reporting lines are structured so as to avoid any conflict of interests. For example, research analysts are not subject to the supervision or control of anyone in Vetiva s Investment Banking or Sales and Trading departments. However, such sales and trading departments may trade, as principal, on the basis of the research analyst s published research. Therefore, the proprietary interests of those Sales and Trading departments may conflict with your interests. Company Disclosure: Vetiva may have financial or beneficial interest in securities or related investments discussed in this report, which could, unintentionally, affect the objectivity of this report. Material interests which Vetiva has with companies or in securities discussed in this report are disclosed hereunder: Company Lafarge Africa PLC Disclosure a. The analyst holds personal positions (directly or indirectly) in a class of the common equity securities of the company b. The analyst responsible for this report as indicated on the front page is a board member, officer or director of the Company c. Vetiva is a market maker in the publicly traded equities of the Company d. Vetiva has been lead arranger or co-lead arranger over the past 12 months of any publicly disclosed offer of securities of the Company e. Vetiva beneficially own 1% or more of the equity securities of the Company f. Vetiva holds a major interest in the debt of the Company g. Vetiva has received compensation for investment banking activities from the Company within the last 12 months h. Vetiva intends to seek, or anticipates to receive compensation for investment banking services from the Company in the next 3 months 4

i. The content of this research report has been communicated with the Company, following which this research report has been materially amended before its distribution j. The Company is a client of Vetiva k. The Company owns more than 5% of the issued share capital of Vetiva Vetiva has other financial or other material interest in the Company Important Regional Disclosures The analyst(s) involved in the preparation of this report may not have visited the material operations of the subject Company (ies) within the past 12 months. Commission is the commission rate or the amount agreed with a customer when setting up an account or at any time after that. To the extent this is a report authored in whole or in part by a Non-U.S. analyst and is made available in the U.S., the following are important disclosures regarding any Non-U.S. analyst contributors: The Non-U.S. research analysts (denoted by an * in the report) are not registered/qualified as research analysts with FINRA; and therefore, may not be subject to the NASD Rule 2711 and NYSE Rule 472 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account. Each analyst (denoted by an *) is a Non-U.S. Analyst and is currently employed by Vetiva. Legal Entities Vetiva Capital Management Limited is registered with the Nigerian Securities & Exchange Commission (SEC) to conduct Issuing House, Financial Advisory, Fund/Portfolio Management business. The subsidiary, Vetiva Securities Limited is licensed by the SEC and the Nigerian Stock Exchange to operate as a Broker/Dealer in the Nigerian Capital Market. Vetiva Trustees Limited, which is also a subsidiary of Vetiva Capital Management Limited, is licensed by the SEC to carry on Trusteeship business in Nigeria. General This research report is based on public information which the research analyst(s) consider credible and reliable. Facts and views presented in this material have not been reviewed by, and may not reflect information known to, professionals in other business areas of Vetiva, including the Investment Banking team and the Wealth Management team, as Vetiva has established information barriers between its Research team and certain business groups. Whilst reasonable care has been taken in preparing this report, no responsibility or liability is accepted either by Vetiva, its officers or any of its employees for any error of fact or opinion expressed herein. No reliance should be placed on the accuracy, fairness or completeness of the information contained in this report as it has not been verified by the research analyst(s) involved or the companies whose securities have been referred to except as otherwise disclosed. Neither Vetiva nor any of its officers or employees including the research analyst(s) warrant or represent the accuracy or completeness of information set out in this report. Any ratings, forecasts, estimates and opinions set forth in this report constitute the analyst(s) position as at the date and time of this report and may not necessarily be so after the report date and time, as they are subject to change without notice. It is also instructive to note that a company s past performance is not necessarily indicative of its future performance as estimates are based on assumptions that may or may not be realized. The value, price or income from investments mentioned in this report may fall, as well as rise, due to economic conditions, industry cycles, market indices, operational or financial conditions of companies or other factors. Thus, Vetiva and its officers and employees shall not accept liability for any loss arising from the use of this report or its contents in making investment decisions or recommendations. This report provides general information only. It is not intended to provide personal investment advice and does not take into account the specific investment objectives, financial situation and the particular needs of any specific person. Investments and securities discussed in this report may not be suitable for all investors and certain investors may not be eligible to purchase or participate in some or all of them. Users of this research report should independently determine the suitability and evaluate the investment risks associated with investments and securities discussed in this report. All investors are solely responsible for their investment decisions. Any decision to purchase or subscribe for securities in any offering must be based solely on existing public information on such security or the information in the prospectus or other offering document issued in connection with such offering, and not on this report. Vetiva, through business units other than Vetiva Research, may have issued and may in the future issue trading ideas or recommendations that are inconsistent with, and reach different conclusions from, the information presented in this report. Such ideas or recommendations reflect the different time frames, assumptions, views and analytical methods of the persons who prepared them, and Vetiva is under no obligation to ensure that such other trading ideas or recommendations are brought to the attention of any recipient of this report. Vetiva may make investment decisions or take proprietary positions that are inconsistent with the recommendations or views in this report. To the extent that this report discusses any legal proceeding or issue, it has not been prepared as nor is it intended to express any legal conclusion, opinion or advice. Information relating to the tax status of companies whose securities are discussed in this report is not intended to provide tax advice or to be used by anyone to provide tax advice. 5

By accepting and making use of this research report, you agree to be bound by the foregoing limitations. No portion of this document may be reprinted, sold or redistributed without the written consent of Vetiva Capital Management Limited. Vetiva research report is disseminated and available primarily electronically, and, in some cases, in printed form. Additional information on recommended securities/instruments is available on request. 2016 Vetiva Capital Management Limited. All rights reserved. 6